Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXVT9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,988
Award facts
- Contract value 100% obligated
- $101,987.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $102K to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on January 28, 2026. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of January 29, 2026. The contract is executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime contract vehicle that runs through December 2026 and provides comprehensive global pharmaceutical support to military healthcare programs. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a separate $999.99 billion IDC with DLA through December 2031, demonstrating the company's significant role in supplying medications, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Zepbound, a diabetes and weight management medication, represents the type of specialized pharmaceutical product regularly procured through this strategic contracting vehicle to support military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FXVT9?
SPE2DR26FXVT9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FXVT9 worth?
The government has obligated $101,988 on SPE2DR26FXVT9.
Is contract SPE2DR26FXVT9 an order under another contract?
Yes. SPE2DR26FXVT9 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVT9 competed?
The extent of competition for SPE2DR26FXVT9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award